Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,3.5X10: medical device reports filed with FDA

5,513 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

5,513
device reports naming the brand
0% of all MAUDE reports · about 788 a year
1,774
reports, 12 months to August 2026
1,200 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 5,513 reports that name the brand "GM Helix Acqua Implant,Ti,3.5X10" (endosseous dental implant), received between July 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

1,774 reports arrived in the 12 months to August 2026, up 48% from 1,200 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (76.4%), loss of osseointegration (18.4%) and difficult to insert (0.8%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0141282Sep 2021: 36Oct 2021: 30Nov 2021: 32Dec 2021: 312022Jan 2022: 23Feb 2022: 32Mar 2022: 67Apr 2022: 53May 2022: 39Jun 2022: 53Jul 2022: 51Aug 2022: 59Sep 2022: 37Oct 2022: 34Nov 2022: 64Dec 2022: 502023Jan 2023: 63Feb 2023: 37Mar 2023: 85Apr 2023: 43May 2023: 69Jun 2023: 80Jul 2023: 64Aug 2023: 54Sep 2023: 68Oct 2023: 92Nov 2023: 68Dec 2023: 822024Jan 2024: 78Feb 2024: 69Mar 2024: 85Apr 2024: 79May 2024: 76Jun 2024: 96Jul 2024: 122Aug 2024: 112Sep 2024: 87Oct 2024: 86Nov 2024: 77Dec 2024: 1432025Jan 2025: 91Feb 2025: 77Mar 2025: 69Apr 2025: 46May 2025: 0Jun 2025: 282Jul 2025: 130Aug 2025: 112Sep 2025: 122Oct 2025: 140Nov 2025: 122Dec 2025: 1622026Jan 2026: 157Feb 2026: 124Mar 2026: 176Apr 2026: 169May 2026: 148Jun 2026: 155Jul 2026: 160Aug 2026: 139

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

06771,3532019: 2220192020: 12420202021: 30920212022: 56220222023: 80520232024: 1,11020242025: 1,35320252026: 1,2282026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,513
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report82.1%4,524
Voluntary report0%0
User facility report0%0
Distributor report17.9%989
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,21276.4%62.8%
Loss of osseointegration1,01718.4%22.4%
Difficult to insertthe device was hard to insert440.8%0.4%
Fracturea broken bone410.7%1.6%
Separation failure50.1%0.1%
Difficult to removethe device was hard to remove10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,55328.2%
Painpain, site not specified1,25122.7%
Inflammationinflammation3907.1%
Hemorrhage/blood loss/bleeding3205.8%
Swelling/ edema2664.8%
Fistula1472.7%
Abscessa collection of pus1232.2%
Hyperresponsive to stimuli1152.1%
Tissue damage701.3%
Hypersensitivity/allergic reaction330.6%
Failure of implant170.3%
Numbnessnumbness170.3%
Sinus perforation150.3%
Inadequate osseointegration30.1%
Swellingswelling20%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,3.5X10Product code DZEAll MAUDE reports
Reports5,5133,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer82.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,3.5X10 reports

How many FDA reports name GM Helix Acqua Implant,Ti,3.5X10?

5,513 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,774 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (76.4%), loss of osseointegration (18.4%), difficult to insert (0.8%), fracture (0.7%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (82.1%) and distributor reports (17.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,3.5X10 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.